| scholarly article | Q13442814 |
| P50 | author | Edgar Pérez-Herrero | Q61159615 |
| P2093 | author name string | Joshua Kim | |
| Janet Hsu | |||
| Silvia Muro | |||
| Zois Tsinas | |||
| Melani Solomon | |||
| Sauradeep Sinha | |||
| P2860 | cites work | Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction | Q24309459 |
| Anti-PEG immunity: emergence, characteristics, and unaddressed questions | Q26825556 | ||
| Role of CD47 as a marker of self on red blood cells | Q28138449 | ||
| Integrin-associated protein (CD47) and its ligands | Q28212839 | ||
| Signal transduction during Fc receptor-mediated phagocytosis | Q28609863 | ||
| Role of target geometry in phagocytosis | Q30477258 | ||
| Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma | Q33893144 | ||
| Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma | Q34144940 | ||
| Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells | Q34760500 | ||
| Folate-targeted therapeutic and imaging agents for cancer | Q34979480 | ||
| The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation | Q35024822 | ||
| Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties | Q35559623 | ||
| Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties | Q36005980 | ||
| A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy. | Q36335331 | ||
| Challenges in design and characterization of ligand-targeted drug delivery systems | Q36346851 | ||
| RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1. | Q36491844 | ||
| New generation of liposomal drugs for cancer | Q36651719 | ||
| The folate receptor: what does it promise in tissue-targeted therapeutics? | Q36749423 | ||
| Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo | Q37051502 | ||
| Shape effects of filaments versus spherical particles in flow and drug delivery | Q37338776 | ||
| Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway | Q37368626 | ||
| Biopharmaceutical drug targeting to the brain | Q37671828 | ||
| Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders | Q37672410 | ||
| Enhancing biodistribution of therapeutic enzymes in vivo by modulating surface coating and concentration of ICAM-1-targeted nanocarriers | Q37724781 | ||
| Application of Smart Nanostructures in Medicine | Q37793084 | ||
| Recent advances in stealth coating of nanoparticle drug delivery systems | Q37974590 | ||
| Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges. | Q38030565 | ||
| Engineering antiphagocytic biomimetic drug carriers | Q38123856 | ||
| The CD47-SIRPα signalling system: its physiological roles and therapeutic application | Q38195828 | ||
| Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles | Q38525935 | ||
| Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials | Q39016563 | ||
| Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease | Q39636269 | ||
| Reduced phagocytosis of colloidal carriers using soluble CD47 | Q40616246 | ||
| A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. | Q40663560 | ||
| Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow | Q40667621 | ||
| Targeted drug delivery to tumors: myths, reality and possibility | Q40868797 | ||
| Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders | Q41121376 | ||
| PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. | Q41774266 | ||
| Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress | Q41915532 | ||
| Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium | Q41933986 | ||
| Size and targeting to PECAM vs ICAM control endothelial delivery, internalization and protective effect of multimolecular SOD conjugates | Q42021062 | ||
| Species- and cell type-specific interactions between CD47 and human SIRPalpha. | Q42064991 | ||
| A DNA-Device that Mediates Selective Endosomal Escape and Intracellular Delivery of Drugs and Biologicals | Q42730201 | ||
| Materials for advanced drug delivery in the 21st century: a focus area for Advanced Drug Delivery Reviews | Q42922558 | ||
| Antibody adsorption and orientation on hydrophobic surfaces | Q44981661 | ||
| Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. | Q46027250 | ||
| SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages | Q46685990 | ||
| How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers. | Q47276739 | ||
| Intravascular ultrasound molecular imaging of atheroma components in vivo | Q47972229 | ||
| Transferrin receptor on endothelium of brain capillaries | Q48602638 | ||
| CD47 functions as a molecular switch for erythrocyte phagocytosis. | Q50514895 | ||
| Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice. | Q50948507 | ||
| Trans-endocytosis of CD47 and SHPS-1 and its role in regulation of the CD47-SHPS-1 system. | Q51790431 | ||
| Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Kinase-dependent Pathway | Q57371752 | ||
| Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers | Q59235035 | ||
| Polymer therapeutics: Clinical applications and challenges for development | Q63209558 | ||
| Inflammation-specific T1 imaging using anti-intercellular adhesion molecule 1 antibody-conjugated gadolinium diethylenetriaminepentaacetic acid | Q80184841 | ||
| Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1/CD31): A Multifunctional Vascular Cell Adhesion Molecule | Q83207652 | ||
| P921 | main subject | nanocarrier | Q17153796 |
| P304 | page(s) | 14-25 | |
| P577 | publication date | 2017-09-06 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance | |
| P478 | volume | 147 |
| Q92144962 | Alterations in Cellular Processes Involving Vesicular Trafficking and Implications in Drug Delivery |
| Q92666184 | Biodistribution, biocompatibility and targeted accumulation of magnetic nanoporous silica nanoparticles as drug carrier in orthopedics |
| Q58803479 | The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery |
| Q92114834 | Unprecedently high targeting specificity toward lung ICAM-1 using 3DNA nanocarriers |
Search more.